A decade of discovery and development of new anti-malarial medicines has led to a
renewed focus on malaria elimination and eradication. Changes in the way new anti …

Despite substantial scientific progress over the past two decades, malaria remains a
worldwide burden that causes hundreds of thousands of deaths every year. New, affordable …

This document is a PDF generated from the WHO Guidelines for malaria hosted on the
MAGICapp online platform: https://app. magicapp. org/#/guideline/6287. Each time the …

Updating of systematic reviews is generally more efficient than starting all over again when
new evidence emerges, but to date there has been no clear guidance on how to do this. This …

WHO guideline on health workforce development, attraction, recruitment and retention in
rural and remote areas. Web Annexes ISBN 978-92-4-002424-3 (electronic version)© World …

Background Intermittent treatment with sulfadoxine–pyrimethamine is widely recommended
for the prevention of malaria in pregnant women in Africa. However, with the spread of …

Background Dihydroartemisinin-piperaquine has been adopted as first-line artemisinin
combination therapy (ACT) for multidrug-resistant Plasmodium falciparum malaria in …

Background Artemether–lumefantrine and artesunate–amodiaquine are used as first-line
artemisinin-based combination therapies (ACTs) in west Africa. Pyronaridine–artesunate …

Malaria, as a major global health problem, continues to affect a large number of people each
year, especially those in developing countries. Effective drug discovery is still one of the …

Background Intermittent preventive treatment (IPT) for malaria is used in infants, children,
adults, and pregnant women. Dihydroartemisinin-piperaquine (DP) is an effective, well …